Lux Venture Partners V, LLC

Insider Reports History

Location
New York, NY
Signature
/s/ Josh Wolfe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lux Venture Partners V, LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eikon Therapeutics, Inc. 10%+ Owner Common Stock 2,294,653 06 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Series A-1 Preferred Stock 0 06 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Series A Preferred Stock 0 06 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Series B-1 Preferred Stock 0 06 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 06 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Series C-1 Preferred Stock 0 06 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Series C Preferred Stock 0 06 Feb 2026 Indirect
Eikon Therapeutics, Inc. 10%+ Owner Series D Preferred Stock 0 06 Feb 2026 Indirect

Insider Reports Filed by Lux Venture Partners V, LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EIKN Eikon Therapeutics, Inc. 04 Feb 2026 15 +$4,999,968 4 10%+ Owner 06 Feb 2026, 18:25
EIKN Eikon Therapeutics, Inc. 04 Feb 2026 0 $0 3 10%+ Owner 04 Feb 2026, 21:11